ClinicalTrials.gov
public full text
Public Domain
Safety of Dabigatran Etexilate in Blood Clot Prevention in Children
This open-label, single arm prospective cohort study will assess the safety of dabigatran etexilate in secondary prevention of venous thromboembolism in paediatric patients. Children from 0 to less than 18 years of age will be eligible to participate.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Rivaroxaban for Treatment in Venous or Arterial Thrombosis in Neonates#807553
- KiteLock 4% EDTA Lock Solution for the Prevention of Occlusions in Children With Intestinal Failure#967941
- Thrombosis Outcomes in Pediatric Venous Thromboembolism#363516
- Prospective Record Of the Use of Dabigatran in Patients With Acute Stroke or TIA#902634
- Inpatient Characteristics and Outcomes of Venous Thromboembolism Among Children and Adolescents.#275643
Record · ID 908169
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive